VIT-ALK, a Novel Alectinib-Sensitive Fusion Gene in Lung Adenocarcinoma

被引：4
|
作者：
Hu, Song [1 ]
Li, Qing [2 ]
Peng, Wanda [1 ]
Feng, Chunlai [1 ]
Zhang, Sujuan [1 ]
Li, Chong [1 ]
机构：
[1] Soochow Univ, Affiliated Hosp 3, Dept Resp Med, Changzhou 213000, Jiangsu, Taiwan
[2] Soochow Univ, Affiliated Hosp 3, Dept Pathol, Changzhou, Jiangsu, Taiwan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 05期
关键词：
D O I：
10.1016/j.jtho.2017.11.134
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E72 / E74
页数：4
相关论文
共 50 条
  • [41] ALK Rearrangement Positive Lung Adenocarcinoma in Pregnancy Treated With Alectinib: A Case Report
    Gonzalez-Mosquera, Luis F.
    Abu Rous, Fawzi
    Rogers, Alexandra
    Smith, Nicolina
    Goyert, Gregory
    Gadgeel, Shirish
    [J]. CLINICAL LUNG CANCER, 2024, 25 (02) : e77 - e80
  • [42] STRN-ALK, A Novel In-Frame Fusion With Response to Alectinib
    Nagasaka, Misako
    Sarvadevabatla, Nagaratna
    Iwata, Shawn
    Ge, Yubin
    Sukari, Ammar
    Klosowski, Christian
    Yanagihara, Ronald
    [J]. JTO CLINICAL AND RESEARCH REPORTS, 2021, 2 (02):
  • [43] A Lung Adenocarcinoma with a STRN-ALK Rearrangement Was Poorly Responsive to Alectinib Treatment
    Iida, Y.
    Nakanishi, Y.
    Takahashi, N.
    Nishimaki, H.
    Nishizawa, T.
    Nakagawa, Y.
    Shimizu, T.
    Gon, Y.
    Masuda, S.
    Hashimoto, S.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1953 - S1953
  • [44] Lung adenocarcinoma with a novel SRBD1-ALK Fusion responding to crizotinib
    Chen, Yao
    Zhang, Xiaochen
    Jiang, Qi
    Wang, Bo
    Wang, Yina
    Yan Junrong
    [J]. LUNG CANCER, 2020, 146 : 370 - 372
  • [45] HIP1-ALK, a Novel Fusion Protein Identified in Lung Adenocarcinoma
    Hong, Mineui
    Kim, Ryong Nam
    Song, Ji-Young
    Choi, So-Jung
    Oh, Ensel
    Lira, Maruja E.
    Mao, Mao
    Takeuchi, Kengo
    Han, Joungho
    Kim, Jhingook
    Choi, Yoon-La
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (03) : 419 - 422
  • [46] Identification of a Novel EML4-ALK Fusion Transcript in Lung Adenocarcinoma
    To, K.
    Tong, J. H. M.
    Law, P. P. Y.
    Chau, S. L.
    Lung, R. W. M.
    Yeung, S. F.
    Kang, W.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (09) : S218 - S219
  • [47] BIRC6-ALK, a Novel Fusion Gene in ALK Break-Apart FISH-Negative Lung Adenocarcinoma, Responds to Crizotinib
    Shan, Ling
    Jiang, Peidi
    Xu, Feng
    Zhang, Weilong
    Guo, Lei
    Wu, Jian
    Zeng, Yixin
    Jiao, Yuchen
    Ying, Jianming
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (06) : E37 - E39
  • [48] Effectiveness of alectinib and osimertinib in a brain metastasized lung adenocarcinoma patient with concurrent EGFR mutations and DCTN1-ALK fusion
    Yin, Qiang
    Guo, Taiyan
    Zhou, Yangyang
    Sun, Leina
    Meng, Maobin
    Ma, Li
    Wang, Xiaoguang
    [J]. THORACIC CANCER, 2022, 13 (04) : 637 - 642
  • [49] Novel lung cancer drug targets patients with ALK fusion gene
    不详
    [J]. PHARMACOGENOMICS, 2011, 12 (11) : 1512 - 1512
  • [50] First case report of a novel KIF13A-ALK fusion in a lung adenocarcinoma patient and response to alectinib with a 4-year follow-up
    Mo, Zheng
    Cai, Cunliang
    Yao, Jingjing
    Zhao, Jingquan
    Zhang, Mingqiang
    Liu, Hao
    Mu, Xiangdong
    [J]. FRONTIERS IN GENETICS, 2023, 14
12345